4IDF Clinical Guidelines Task Force.Global guideline for Type 2Diebetes:recommendations for standard,comprehensive,and minimalcare[J].Diebet Med,2006,23(6):579-593.
5Nathna DM,Buse JB,Davidson MB,et al.Management of hyperglycaemia in type 2 diebetes:a consensus algorithm for the initiation and adjustment of therapy:a consensus statement from the American Diebetes Association and the Europen Association for the Study of Diebetes[J].Diabetologia,2006,49(8):1711-1721.
4Kernan WN, Viscoli CM, lnzucchi SE,et al. Prevalence of abnormal glucose tolerance following transient ischemic attack or ischemic stroke [ J ]. Arch Intern Me,2005,165 ( 2 ) :227 - 233.
5Bartnik M, Ryden L, Ferrari R, et al. The prevalence of abnormal glucose regulation in patients with eoronary artery disease across Europethe Euro heart survey on diabetes and the heart [J]. Euro Heart J ,2004,25 (21) :1880 - 1890.
7Follow - up report on the diagnosis of diabetes mellitus - the expert committee on the diagnosis and classification of dialetes mellilus[J]. Diabetes Care,2003,26 ( 11 ) :3160 - 3167.
8Deedwania PC. Diabetes and hypertension, the deadly duct importance,therapeulic strategy, and selection of drug therapy[J]. Cardiol Clin ,2005,23 ( 1 ) :139 - 152.
9Stratton IM,Adler AI, Neil HA,et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes ( UKPDS 35 ) : prospective observational study [J]. BMJ, 2000, 321:405 - 412.
10Jinping Weng,Yanbing Li,Wen Xu,et al. Effect of intensive insulin therapy on β-cell function and glyeaemic conronl in patients with newly diagnosed type 2 diahetes:a muhicentrntre randomized parallel-group trial[J]. Lancet, 2008,371 (9626) : 1577 - 1580.
